Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain. (Q38157791)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24178954%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24178954%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24178954%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Stephen D Skaper

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24178954%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Laura Facci

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24178954%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Mariella Fusco

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24178954%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Maria Federica Della Valle

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24178954%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Morena Zusso

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24178954%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Barbara Costa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24178954%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

1 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24178954%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24178954%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24178954%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24178954%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

79-94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24178954%20AND%20SRC:MED&resulttype=core&format=json

Enzymatic pathways that regulate endocannabinoid signaling in the nervous system

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Activation and desensitization of TRPV1 channels in sensory neurons by the PPARα agonist palmitoylethanolamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Randomized split-mouth study on postoperative effects of palmitoylethanolamide for impacted lower third molar surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Non-neuronal cell modulation relieves neuropathic pain: efficacy of the endogenous lipid palmitoylethanolamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

P2 receptor-mediated signaling in mast cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Occipital Neuralgia Responding to Palmitoylethanolamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Misdiagnosed chronic pelvic pain: pudendal neuralgia responding to a novel use of palmitoylethanolamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Control of pain initiation by endogenous cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

The role of the immune system in the generation of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Effects of palmitoylethanolamide on immunologically induced histamine, PGD2 and TNFalpha release from canine skin mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

The effect of egg yolk in diets on anaphylactic arthritis (passive Arthus phenomenon) in the guinea pig

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo-oxygenase systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Microglia and neurodegeneration: the role of systemic inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappaB nuclear signalling in dorsal root ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Effects of intra-ventrolateral periaqueductal grey palmitoylethanolamide on thermoceptive threshold and rostral ventromedial medulla cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Perineural mast cells are specifically enriched in pancreatic neuritis and neuropathic pain in pancreatic cancer and chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

N-palmitoylethanolamide in the treatment of neuropathic pain associated with lumbosciatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Recommendations for the pharmacological management of neuropathic pain: an overview and literature update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Administration of endocannabinoids prevents a referred hyperalgesia associated with inflammation of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

A novel neuroimmune mechanism in cannabinoid-mediated attenuation of nerve growth factor-induced hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

The mast cell-nerve functional unit: a key component of physiologic and pathophysiologic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

The impact of neuropathic pain in the chronic pelvic pain population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

High levels of N-palmitoylethanolamide and N-stearoylethanolamide in microdialysate samples from myalgic trapezius muscle in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

The adjuvant use of N-palmitoylethanolamine and transpolydatin in the treatment of endometriotic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Glial cells and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

N-acylethanolamines, anandamide and food intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Effect of palmitoylethanolamide-polydatin combination on chronic pelvic pain associated with endometriosis: preliminary observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Peroxisome proliferator-activated receptor α mediates acute effects of palmitoylethanolamide on sensory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

The burden associated with neuropathic pain in Western Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Mast cell degranulation distinctly activates trigemino-cervical and lumbosacral pain pathways and elicits widespread tactile pain hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

The search for the palmitoylethanolamide receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Palmitoylethanolamide reduces formalin-induced neuropathic-like behaviour through spinal glial/microglial phenotypical changes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Combination drug therapy for chronic pain: a call for more clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Neurophysiology of arthritis pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Pathological and protective roles of glia in chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Homeostatic regulation of the endoneurial microenvironment during development, aging and in response to trauma, disease and toxic insult

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Immune and inflammatory mechanisms in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Microglia produce and hydrolyze palmitoylethanolamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Vestibulodynia: synergy between palmitoylethanolamide + transpolydatin and transcutaneous electrical nerve stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Toll-like receptors in chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

The neuropathic pain market

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Molecular characterization of a phospholipase D generating anandamide and its congeners

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

The endocannabinoid system as an emerging target of pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Thermosensitive Polymeric Micelles for Targeted Drug Delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Palmitoylethanolamide stimulation induces allopregnanolone synthesis in C6 Cells and primary astrocytes: involvement of peroxisome-proliferator activated receptor-α.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Interactions between the immune and nervous systems in pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Involvement of the peroxisome proliferator-activated receptor (PPAR) alpha in vascular response of endocannabinoids in the bovine ophthalmic artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Cytokine modulation is necessary for efficacious treatment of experimental neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Improvement in solubility of poor water-soluble drugs by solid dispersion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Implication of allopregnanolone in the antinociceptive effect of N-palmitoylethanolamide in acute or persistent pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Resolution of inflammation: the beginning programs the end

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Palmitoylethanolamide: biochemistry, pharmacology and therapeutic use of a pleiotropic anti-inflammatory lipid mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Microglia and mast cells: two tracks on the road to neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Epidemiology of neuropathic pain and its impact on quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Anti-inflammatory therapy in chronic disease: challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Induction of astrocyte differentiation by propentofylline increases glutamate transporter expression in vitro: heterogeneity of the quiescent phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Mast cells: target and source of neuropeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

The prevalence and impact of chronic pain with neuropathic pain symptoms in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Palmitoylethanolamide restores myelinated-fibre function in patients with chemotherapy-induced painful neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Mast cells and immunoregulation/immunomodulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

The N-acylethanolamine-hydrolyzing acid amidase (NAAA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Biosynthetic pathways of bioactive N-acylethanolamines in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Microglial regulation of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Proceedings of the CHANGE PAIN Expert Summit in Rome, June 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Endogenous cannabinoid receptor agonists inhibit neurogenic inflammations in guinea pig airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Mast cell tryptase induces microglia activation via protease-activated receptor 2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Proinflammatory Stimuli ControlN-Acylphosphatidylethanolamine-Specific Phospholipase D Expression in Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Inflammation and hyperalgesia induced by nerve injury in the rat: a key role of mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

A new definition of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-013-0191-7

Involvement of the L-arginine/nitric oxide/cyclic guanosine monophosphate pathway in peripheral antinociception induced by N-palmitoyl-ethanolamine in rats

21 January 2018

1 reference

12 December 2020

Mechanism-based treatment of pain

1 reference

12 December 2020

1 reference

12 December 2020

Palmitoylethanolamide versus a nonsteroidal anti-inflammatory drug in the treatment of temporomandibular joint inflammatory pain

1 reference

12 December 2020

The resolution of inflammation

1 reference

12 December 2020

Palmitoylethanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR-alpha-mediated mechanism.

1 reference

12 December 2020

Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility.

1 reference

12 December 2020

Use of palmitoylethanolamide in the entrapment neuropathy of the median in the wrist

1 reference

12 December 2020

The Interaction Between Intrathecal Administration of Low Doses of Palmitoylethanolamide and AM251 in Formalin-Induced Pain Related Behavior and Spinal Cord IL1-β Expression in Rats

1 reference

12 December 2020

Mast cells: a new target in the treatment of complex regional pain syndrome?

1 reference

12 December 2020

Endocannabinoids: a unique opportunity to develop multitarget analgesics

1 reference

12 December 2020

CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system

1 reference

12 December 2020

Acute Intracerebroventricular Administration of Palmitoylethanolamide, an Endogenous Peroxisome Proliferator-Activated Receptor- Agonist, Modulates Carrageenan-Induced Paw Edema in Mice

1 reference

12 December 2020

Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats.

1 reference

12 December 2020

Multimodal stepped care approach with acupuncture and PPAR-α agonist palmitoylethanolamide in the treatment of a patient with multiple sclerosis and central neuropathic pain

1 reference

12 December 2020

Palmitoylethanolamide and stearoylethanolamide levels in the interstitium of the trapezius muscle of women with chronic widespread pain and chronic neck-shoulder pain correlate with pain intensity and sensitivity

1 reference

12 December 2020

Role of mast cell activation in inducing microglial cells to release neurotrophin

1 reference

12 December 2020

Particle size reduction to the nanometer range: a promising approach to improve buccal absorption of poorly water-soluble drugs

1 reference

12 December 2020

Metabolism of N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type

1 reference

12 December 2020

Micronized palmitoylethanolamide reduces the symptoms of neuropathic pain in diabetic patients

1 reference

12 December 2020

The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief

1 reference

12 December 2020

Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma.

1 reference

12 December 2020

Effectiveness of the association micronized N-Palmitoylethanolamine (PEA)-transpolydatin in the treatment of chronic pelvic pain related to endometriosis after laparoscopic assessment: a pilot study

1 reference

12 December 2020